About Inozyme Pharma (INZY)
Inozyme Pharma, Inc. is a rare disease biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. It is focused on develop... Read more
- USD4.33
- USD4.51
- USD4.23
- USD7.80
- -30.50%
- --
- 511.36k
- 864.80k
- 279M
- 2.69
- -24.70%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
